PXMD
Income statement / Annual
Last year (2023), PaxMedica, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, PaxMedica, Inc. Common Stock's net income was -$18.29 M.
See PaxMedica, Inc. Common Stock’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$3.91 M
|
$1.79 M
|
$2.22 M
|
$936,776.00
|
$484,113.00
|
| General & Administrative
Expenses |
$12.23 B
|
$8.82 M
|
$4.97 M
|
$4.63 M
|
$114,496.00
|
| Selling & Marketing
Expenses |
-$12.22 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.23 M
|
$8.82 M
|
$4.97 M
|
$4.63 M
|
$114,496.00
|
| Other Expenses |
$0.00 |
-$5.51 M |
$173,353.00 |
-$53,541.00 |
$0.00 |
| Operating Expenses |
$16.15 M |
$10.60 M |
$7.20 M |
$5.57 M |
$598,609.00 |
| Cost And Expenses |
$16.15 M |
$10.60 M |
$7.20 M |
$5.57 M |
$598,609.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$9,165.00 |
$5,237.00 |
$2.81 M |
$609,458.00 |
$0.00 |
| Depreciation &
Amortization |
$167,895.00
|
-$5.90 M
|
$173,353.00
|
-$53,541.00
|
$171,860.00
|
| EBITDA |
-$16.15 M
|
-$10.60 M
|
-$7.20 M
|
-$5.62 M
|
-$598,609.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$2.14 M
|
-$4.20 M
|
-$3.03 M
|
-$2.26 M
|
$0.00
|
| Income Before Tax |
-$18.29 M |
-$14.80 M |
-$10.23 M |
-$7.83 M |
-$598,609.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$167,895.00 |
$4.19 M |
$2.81 M |
$662,999.00 |
-$171,860.00 |
| Net Income |
-$18.29 M |
-$14.80 M |
-$13.03 M |
-$8.49 M |
-$598,609.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-11 |
-28.79 |
-18.81 |
-12.25 |
-0.0598 |
| EPS Diluted |
-11 |
-28.79 |
-18.81 |
-12.25 |
-0.0598 |
| Weighted Average Shares
Out |
$1.66 M
|
$514,216.00
|
$692,910.00
|
$692,910.00
|
$10.02 M
|
| Weighted Average Shares
Out Diluted |
$1.66 M
|
$514,216.00
|
$692,910.00
|
$692,910.00
|
$10.02 M
|
| Link |
|
|
|
|
|
